| Oct 22 |
3 US Penny Stocks With Market Caps Larger Than $50M
|
| Oct 10 |
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
|
| Aug 8 |
Allakos GAAP EPS of -$0.30
|
| Aug 7 |
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
|
| Jul 23 |
Can Allakos (NASDAQ:ALLK) Afford To Invest In Growth?
|
| Jun 26 |
Allakos drops after early-stage results for lead asset
|
| May 28 |
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
|
| May 10 |
Allakos Inc. Reports Increased Losses in Q1 2024, Misses Analyst Earnings Predictions
|
| May 9 |
Allakos GAAP EPS of -$0.81 misses by $0.37
|
| May 9 |
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
|
